Jaguar Health Inc (JAGX)
0.1699
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
0.16
-0.01
(-5.83%)
After-Hours: 06:34
Jaguar Health Total Liabilities (Quarterly): 45.87M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 45.87M |
| September 30, 2023 | 43.96M |
| June 30, 2023 | 46.34M |
| March 31, 2023 | 49.27M |
| December 31, 2022 | 48.81M |
| September 30, 2022 | 47.69M |
| June 30, 2022 | 47.13M |
| March 31, 2022 | 44.80M |
| December 31, 2021 | 41.41M |
| September 30, 2021 | 37.70M |
| June 30, 2021 | 37.75M |
| March 31, 2021 | 36.82M |
| December 31, 2020 | 25.64M |
| September 30, 2020 | 28.43M |
| June 30, 2020 | 36.04M |
| March 31, 2020 | 27.04M |
| December 31, 2019 | 25.74M |
| September 30, 2019 | 15.25M |
| June 30, 2019 | 28.71M |
| Date | Value |
|---|---|
| March 31, 2019 | 33.87M |
| December 31, 2018 | 35.66M |
| September 30, 2018 | 35.80M |
| June 30, 2018 | 32.14M |
| March 31, 2018 | 29.26M |
| December 31, 2017 | 26.37M |
| September 30, 2017 | 28.18M |
| June 30, 2017 | 11.21M |
| March 31, 2017 | 9.766M |
| December 31, 2016 | 6.017M |
| September 30, 2016 | 5.375M |
| June 30, 2016 | 5.638M |
| March 31, 2016 | 7.327M |
| December 31, 2015 | 8.006M |
| September 30, 2015 | 8.276M |
| June 30, 2015 | 2.744M |
| March 31, 2015 | 16.70M |
| December 31, 2014 | 5.350M |
| June 30, 2014 | 10.12M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
15.25M
Minimum
Sep 2019
49.27M
Maximum
Mar 2023
37.60M
Average
37.75M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| BioSig Technologies Inc | 4.685M |
| BioVie Inc | 14.00M |
| First Wave BioPharma Inc | 3.280M |
| Genprex Inc | 3.254M |
| Adial Pharmaceuticals Inc | 0.6531M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 50.76M |
| Shareholders Equity (Quarterly) | 4.961M |
| Debt to Equity Ratio | 7.228 |
| Current Ratio | 1.999 |
| Net Debt Paydown Yield | -7.41% |